Research map: Comparison of incontinence quality of life scores in patients with type 2 diabetes mellitus treated and not treated with sodium-glucose cotransporter 2 inhibitors

Back to the article

Papers in this map

  1. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes · Bernard Zinman · 2015 · 12293 citations · Cited by this paper
  2. Promising results amid persistent disparities in real-world adherence to multitarget stool DNA testing · 2026 · Related
  3. Dapagliflozin in Patients with Chronic Kidney Disease · Hiddo J.L. Heerspink · 2020 · 5532 citations · Cited by this paper
  4. Original Abstracts from the 22nd Annual Meeting of ISMPP · 2026 · Related
  5. An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction · Bernard T. Haylen · 2009 · 3099 citations · Cited by this paper
  6. Real-world comparison of androgen receptor pathway ınhibitors versus docetaxel as first-line treatment in metastatic hormone-sensitive prostate cancer · 2026 · Related
  7. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association · Chiadi E. Ndumele · 2023 · 2076 citations · Cited by this paper
  8. Quantifying US healthcare provider preferences for the treatment of post-transplant cytomegalovirus infection using a discrete choice experiment · 2026 · Related
  9. Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus · Hiddo J.L. Heerspink · 2016 · 1379 citations · Cited by this paper
  10. Serum calcium and liver injury in people living with HIV: a longitudinal cohort study in Southeast China · 2026 · Related
  11. Urinary Incontinence in Women · Emily Spencer Lukacz · 2017 · 566 citations · Cited by this paper
  12. A novel hypothesis for stroke prediction, introducing CHA 2 DS 2 -VAScF · 2026 · Related
  13. Quality of life of persons with urinary incontinence: Development of a new measure · Todd H. Wagner · 1996 · 519 citations · Cited by this paper
  14. Seizing the opportune moment: early use of antiplatelet therapy for thrombolysis · 2026 · Related
  15. What Is the Most Bothersome Lower Urinary Tract Symptom? Individual- and Population-level Perspectives for Both Men and Women · Arnav Agarwal · 2014 · 268 citations · Cited by this paper
  16. Tirzepatide compared with semaglutide in obesity disease: a subpopulation analysis applying Japan Society for the Study of Obesity criteria in the global SURMOUNT-5 trial · 2026 · Related
  17. Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure · Natalie Mordi · 2020 · 255 citations · Cited by this paper
  18. Original Abstracts from the 2026 European Meeting of ISMPP · 2026 · Related
  19. Pregnancy‐ and obstetric‐related risk factors for urinary incontinence, fecal incontinence, or pelvic organ prolapse later in life: A systematic review and meta‐analysis · Monique A. H. Hage‐Fransen · 2020 · 180 citations · Cited by this paper
  20. Bladder Dysfunction in Diabetes Mellitus · Saeid Golbidi · 2010 · 158 citations · Cited by this paper
  21. Pelvic Floor Disorders, Diabetes, and Obesity in Women · Jean M. Lawrence · 2007 · 144 citations · Cited by this paper
  22. The association between diabetes mellitus and urinary incontinence in adult women · Yenal Izci · 2009 · 79 citations · Cited by this paper
  23. Clinical risk factors predicting genital fungal infections with sodium–glucose cotransporter 2 inhibitor treatment: The ABCD nationwide dapagliflozin audit · Ken Y Thong · 2017 · 65 citations · Cited by this paper
  24. SGLT2 Inhibitor: Not a Traditional Diuretic for Heart Failure · Ashish Kumar Verma · 2020 · 62 citations · Cited by this paper
  25. Clinical Recommendations for Managing Genitourinary Adverse Effects in Patients Treated with SGLT-2 Inhibitors: A Multidisciplinary Expert Consensus · Juan José Gorgojo Martínez · 2024 · 43 citations · Cited by this paper
  26. Body mass index, abdominal fatness, weight gain and the risk of urinary incontinence: a systematic review and dose–response meta‐analysis of prospective studies · Dagfinn Aune · 2019 · 41 citations · Cited by this paper
  27. Reasons for Discontinuing Treatment with Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes in Real-World Settings: The KAMOGAWA-A Study · Yuto Saijo · 2023 · 33 citations · Cited by this paper
  28. Sodium‐glucose cotransporter 2 inhibitors and outcomes in transthyretin amyloid cardiomyopathy: Systematic review and meta‐analysis · Paschalis Karakasis · 2025 · 33 citations · Cited by this paper
  29. Quality of life in patients with multiple sclerosis and urinary disorders: Reliability and validity of Turkish-language version of Incontinence Quality of Life Scale · Sibel Eyigör · 2010 · 32 citations · Cited by this paper
  30. The impact of Diabetes Mellitus on Lower urinary tract symptoms (LUTS) in both male and female patients · Efstathios Papaefstathiou · 2018 · 28 citations · Cited by this paper
  31. Lower Urinary Tract Symptoms Should Be Queried When Initiating Sodium Glucose Co-Transporter 2 Inhibitors · Nicolas Krepostman · 2021 · 28 citations · Cited by this paper
  32. Does treatment with sodium-glucose co-transporter-2 inhibitors have an effect on sleep quality, quality of life, and anxiety levels in people with Type 2 diabetes mellitus? · Serdar Şahin · 2020 · 19 citations · Cited by this paper
  33. Drug-induced Urinary Retention: An Analysis of a National Spontaneous Adverse Drug Reaction Reporting Database · Salvatore Crisafulli · 2021 · 16 citations · Cited by this paper
  34. Changes in overactive bladder symptoms after sodium glucose cotransporter‐2 inhibitor administration to patients with type 2 diabetes · Junpei Shikuma · 2018 · 10 citations · Cited by this paper
  35. Associations Between Sodium-Glucose Co-transporter 2 Inhibitors and Urologic Diseases: Implications for Lower Urinary Tract Symptoms From a Multi-State Health System Analysis · Bradley John Roth · 2024 · 10 citations · Cited by this paper
  36. SGLT2 Inhibitors in the Management of Cardio-Renal-Metabolic Syndrome: A New Therapeutic Era · Konstantinos Grigoriou · 2025 · 9 citations · Cited by this paper
  37. Sex Differences in Prevalence and Patient Behavior Regarding Lower Urinary Tract Symptoms Among Japanese Medical Checkup Examinees · Manami Kinjo · 2020 · 6 citations · Cited by this paper
  38. Do sodium glucose co-transporter-2 (sglt-2) inhibitors affect lower urinary tract, sleep and quality of life in people with type 2 diabetes? · Gökçen Güngör Semiz · 2024 · 4 citations · Cited by this paper
  39. Urinary incontinence in US adults aged ≥55 years with type 2 diabetes and indications for SGLT2is: NHANES 2013–2020 · Alexandra K. Lee · 2025 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)